- Home
- TARA vs BTMD Comparison
TARA vs BTMD Comparison
Compare TARA & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- BTMD
- Stock Information
- Founded
- TARA N/A
- BTMD 2012
- Country
- TARA United States
- BTMD United States
- Employees
- TARA N/A
- BTMD N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- TARA Health Care
- BTMD Health Care
- Exchange
- TARA Nasdaq
- BTMD Nasdaq
- Market Cap
- TARA 202.8M
- BTMD 198.2M
- IPO Year
- TARA N/A
- BTMD N/A
- Fundamental
- Price
- TARA $4.55
- BTMD $5.64
- Analyst Decision
- TARA Strong Buy
- BTMD Strong Buy
- Analyst Count
- TARA 3
- BTMD 5
- Target Price
- TARA $22.67
- BTMD $9.11
- AVG Volume (30 Days)
- TARA 523.2K
- BTMD 106.7K
- Earning Date
- TARA 03-12-2025
- BTMD 03-11-2025
- Dividend Yield
- TARA N/A
- BTMD N/A
- EPS Growth
- TARA N/A
- BTMD N/A
- EPS
- TARA N/A
- BTMD 0.21
- Revenue
- TARA N/A
- BTMD $193,060,000.00
- Revenue This Year
- TARA N/A
- BTMD $9.22
- Revenue Next Year
- TARA N/A
- BTMD $14.46
- P/E Ratio
- TARA N/A
- BTMD $26.82
- Revenue Growth
- TARA N/A
- BTMD 4.84
- 52 Week Low
- TARA $1.60
- BTMD $3.65
- 52 Week High
- TARA $10.48
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- TARA 41.78
- BTMD 42.92
- Support Level
- TARA $5.04
- BTMD $5.46
- Resistance Level
- TARA $6.20
- BTMD $6.03
- Average True Range (ATR)
- TARA 0.40
- BTMD 0.29
- MACD
- TARA -0.22
- BTMD -0.04
- Stochastic Oscillator
- TARA 2.37
- BTMD 20.00
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.